Boston scientific obtains ce mark for acurate prime™ aortic valve system

Marlborough, mass. , aug. 27, 2024 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced it has obtained ce mark for the acurate prime™ aortic valve system, the newest transcatheter aortic valve replacement (tavr) technology in the company's structural heart portfolio.
BSX Ratings Summary
BSX Quant Ranking